Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

Published:2016-11-25 Issue:1 Volume:9 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Cai Bo,Guo Mei,Wang Yao,Zhang Yajing,Yang Jun,Guo Yelei,Dai Hanren,Yu Changlin,Sun Qiyun,Qiao Jianhui,Hu Kaixun,Zuo Hongli,Dong Zheng,Zhang Zechuan,Feng Mingxing,Li Bingxia,Sun Yujing,Liu Tieqiang,Liu Zhiqing,Wang Yi,Huang Yajing,Yao Bo,Han Weidong,Ai Huisheng

Funder

National Natural Science Foundation of China

Science and Technology Planning Project of Beijing City

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-016-0357-z.pdf

Reference13 articles.

1. Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507–17.

2. Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015;385:517–28.